Sarcoidosis, Pulmonary
Information
- Disease name
- Sarcoidosis, Pulmonary
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04314193 | Active, not recruiting | Phase 4 | Effectiveness of Methotrexate Versus Prednisolone as First-line Therapy for Pulmonary Sarcoidosis | June 1, 2020 | July 2026 |
| NCT05314517 | Active, not recruiting | Phase 2 | A Study to Assess the Efficacy and Safety of Namilumab in Participants With Chronic Pulmonary Sarcoidosis | August 31, 2022 | June 2025 |
| NCT03320070 | Completed | Phase 4 | Acthar Gel in Participants With Pulmonary Sarcoidosis | February 21, 2018 | November 15, 2021 |
| NCT03324503 | Completed | N/A | A Study to Estimate the Effect Sizes of HRCT Endpoints in Response to Glucocorticoid Induction Therapy in Subjects With Pulmonary Sarcoidosis | December 8, 2017 | November 15, 2019 |
| NCT03336736 | Completed | The Role of Physical Activity and Diet Within Pulmonary Sarcoidosis | November 7, 2017 | June 15, 2018 | |
| NCT00279708 | Completed | Phase 2 | Atorvastatin to Treat Pulmonary Sarcoidosis | January 2006 | December 2015 |
| NCT03140644 | Completed | N/A | SARCOLOWDOSE : Ultra-low Dose CT Scan and MRI in Thoracic Sarcoidosis | May 16, 2017 | October 15, 2021 |
| NCT03727451 | Completed | Phase 2 | A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or Sarcoidosis | January 30, 2019 | June 15, 2022 |
| NCT03793439 | Completed | Phase 1 | Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis | May 15, 2019 | June 24, 2021 |
| NCT04020380 | Completed | Phase 2 | Azithromycin a Treatment for Pulmonary Sarcoidosis | September 6, 2019 | June 20, 2020 |
| NCT04803617 | Completed | Investigation of Pectoralis Muscle Strength in Elderly With Interstitial Lung Disease | January 23, 2017 | June 23, 2017 | |
| NCT05311150 | Completed | N/A | An RCT of NBI vs. White Light Guided Endobronchial Biopsy in Suspected Sarcoidosis | January 1, 2022 | February 15, 2023 |
| NCT05759221 | Completed | N/A | Peripheral Airway Biopsy in Sarcoidosis | October 20, 2022 | March 31, 2024 |
| NCT05811962 | Completed | The Diagnostic and Prognostic Role of SAA in Intrathoracic Sarcoidosis | January 1, 2014 | December 1, 2022 | |
| NCT05291468 | Not yet recruiting | N/A | the PHENOSAR Trial: Use of Antibiotics in Treatment of Sarcoidosis | January 1, 2023 | June 30, 2023 |
| NCT05910554 | Not yet recruiting | Phase 2 | Investigation of the Efficacy of Metformin Therapy on Pulmonary Sarcoidosis | May 1, 2024 | March 1, 2025 |
| NCT05841758 | Not yet recruiting | Phase 4 | Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis | April 1, 2024 | April 1, 2029 |
| NCT04895111 | Recruiting | Endobronchial Ultrasound Strain Elastography in Sarcoidosis | May 10, 2021 | March 31, 2024 | |
| NCT05567133 | Recruiting | Risk Indicators of Sarcoidosis Evolution-Unified Protocol | January 10, 2023 | March 30, 2026 | |
| NCT03914027 | Recruiting | N/A | Feasibility & Effect of a Tele-rehabilitation Program in Pulmonary Sarcoidosis Pulmonary Sarcoidosis | December 12, 2018 | October 1, 2025 |
| NCT05746039 | Recruiting | Phase 1/Phase 2 | Feasibility of Semaglutide in Advanced Lung Disease | January 29, 2024 | June 28, 2024 |
| NCT05374447 | Recruiting | N/A | Diagnostic Yield of Intranodal Forceps Biopsies in Mediastinal Adenopathy | June 10, 2022 | March 1, 2025 |
| NCT03145922 | Recruiting | Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis | January 2016 | January 2026 | |
| NCT03455686 | Recruiting | N/A | Exploring the Utility of Hyperpolarized 129Xe MRI in Healthy Volunteers and Patients With Lung Disease | April 19, 2018 | December 2024 |
| NCT03260556 | Unknown status | Phase 4 | Pirfenidone for Progressive Fibrotic Sarcoidosis | September 27, 2017 | March 30, 2020 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D017565